Endo International PLC

Pharmaceuticals
Ireland
2016 Revenue (US$ Millions)$4,010
Revenue Growth (%)22.69%
Net Income (US$ Millions)-$3,347
Earnings Per Share (US$)-$15.03
EPS Growth Rate (%)NM
Profit Margin-83.46%
Total Equity (US$ Millions)$2,702
Return on Equity (%)-56.08%
Long Term Debt (US$ Millions)$8,141
Debt To Equity Ratio (%)3.01%
Total Assets (US$ Millions)$14,275
Current Assets (US$ Millions)$2,589
Current Liabilities (US$ Millions)$2,635
Cost of Goods Sold (US$ Millions)$2,635
Inventory Turnover4.05